All In Biotech

Drug Trial Radar · NCT04415658

Intravenous Thyroxine for Heart-Eligible Organ Donors

A Multicenter Randomized Placebo-Controlled Trial of Intravenous Thyroxine for Heart-Eligible Brain Dead Organ Donors

Last checked: Nov 19, 2026Latest source record: Jan 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 838 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

838

Actual

Start

Dec 1, 2020

Primary completion

Nov 6, 2022

Study completion Dec 6, 2022

Sponsor

Lead sponsor
Washington University School of MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Mid-America Transplant
First posted
Jun 4, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 14 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo

Conditions

  • Brain Death
  • Heart Failure

Interventions

  • ThyroxineDrug

    Infusion prepared by mixing 500 μg of drug in 500-ml of normal saline (i.e. concentration of 1 μg/ml) and enclosing the bag in an opaque sleeve. Infusion started at 30 μg/hour (30 ml/hour) for twelve hours.

  • SalineDrug

    The placebo will be a 500-ml bag of normal saline (without active drug) also enclosed in an opaque sleeve. This infusion will also be started at 30 ml/hour for twelve hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Heart TransplantedTime frame: One week
  2. Graft FunctionTime frame: 30 days

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Donor Network of Arizona

    Phoenix, Arizona

  • Lifesharing

    San Diego, California

  • Donor Alliance

    Denver, Colorado

  • OurLegacy

    Maitland, Florida

  • Iowa Donor Network

    North Liberty, Iowa

  • Midwest Transplant Network

    Westwood, Kansas

  • Louisiana Organ Procurement Agency

    Covington, Louisiana

  • Mid-America Transplant Services

    St Louis, Missouri

  • Lifebanc

    Cleveland, Ohio

  • LifeShare of Oklahoma

    Oklahoma City, Oklahoma

  • Southwest Transplant Alliance

    Dallas, Texas

  • Texas Organ Sharing Alliance

    San Antonio, Texas

  • DonorConnect

    Murray, Utah

  • LifeCenter Northwest

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.